Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2023-08-30

Clinical Trial Update: Dexmedetomidine Versus Gabapentin Premedication on the Emergence Agitation After Rhinoplasty [Phase 4]

View source ↗

Summary

Phase 4 trial comparing dexmedetomidine versus gabapentin as premedication to reduce emergence agitation after rhinoplasty is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Dexmedetomidine (Dexmedetomidine)
  • Gabapentin (Gabapentin)

Snippet

Sponsor: Ain Shams University | Conditions: Anesthesia | Phase 4 | Status: COMPLETED